CI Global Health Sciences Corporate Class

Series P CAD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date May 2017
CAD Total net assets ($CAD)
As at 2026-05-29
$137.0 million
NAVPS
As at 2026-06-15
$13.1886
MER (%)
As at 2025-09-30
0.24
Management fee (%) 0.90
Asset class Sector Equity
Currency CAD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.2081

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

P 90024
A ISC 201
DSC SO* 701
LL SO 1701
E 16005
EF 15005
F 224
I 886
O 18005
*No new purchases directly into switch only funds.

Performance2 As at 2026-05-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
-3.65% 7.75% -3.47% -5.57% 14.24% 3.36% 2.05% - 4.58%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.2081
2021-03-26 0.0708
2020-12-18 0.1141
2020-09-25 0.1130
2020-06-26 0.0840
Payable date Total
2020-03-20 0.2055
2019-12-13 0.1173
2019-09-27 0.1312
2019-06-21 0.1228
2019-03-22 0.1957

CI PREFERRED PRICING4

Investment amount Combined fee reduction
$100,000 - $500,000 0.03%
$500,000 - $1,000,000 0.06%
$1,000,000 - $2,500,000 0.12%
$2,500,000 - $5,000,000 0.20%
$5,000,000 and above 0.32%

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series P CAD
 
Portfolio allocations5 As at 2026-05-31
Asset allocation (%)
  • US Equity 87.29
  • International Equity 12.67
  • Cash and Equivalents 0.06
  • Other -0.02
Sector allocation (%)
  • Healthcare 96.77
  • Exchange Traded Fund 3.19
  • Cash and Cash Equivalent 0.06
  • Other -0.02
Geographic allocation(%)
  • United States 87.26
  • United Kingdom 7.06
  • Switzerland 3.37
  • Netherlands 2.29
  • Canada 0.04
  • Other -0.02
Top holdings7
Sector (%)
1. Eli Lilly and Co Drugs 15.49%
2. DexCom Inc Healthcare Equipment 9.75%
3. Thermo Fisher Scientific Inc Healthcare Equipment 8.47%
4. IQVIA Holdings Inc Drugs 8.39%
5. AstraZeneca PLC Drugs 7.06%
6. Stryker Corp Healthcare Equipment 6.19%
7. Johnson & Johnson Drugs 6.13%
8. UnitedHealth Group Inc Healthcare Services 5.94%
9. Merck & Co Inc Drugs 4.65%
10. Intuitive Surgical Inc Healthcare Equipment 4.58%
11. Vertex Pharmaceuticals Inc Drugs 3.30%
12. SPDR S&P Biotech ETF (XBI) Exchange Traded Fund 3.19%
13. AbbVie Inc Drugs 3.06%
14. Danaher Corp Healthcare Equipment 3.01%
15. CVS Health Corp Healthcare Services 2.72%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.